CTLA4 and hyperinsulinemic hypoglycemia, familial, 4: Thus, patients with CTLA4 deficiency have been treated with selective mTOR inhibitors like sirolimus, which specially inhibit effector T-cells and eventually succeed in controlling the autoimmunity [33,34].